PTC Therapeutics Inc

PTCT

Company Profile

  • Business description

    PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.

  • Contact

    500 Warren Corporate Center Drive
    WarrenNJ07059
    USA

    T: +1 908 222-7000

    E: [email protected]

    https://www.ptcbio.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    991

Stocks News & Analysis

stocks

World’s largest miner benefits from copper boom

Copper driven earnings growth underpins higher dividends and fair value upgrade.
stocks

The role of shareholder yield in a portfolio

How to identify durable dividend payers.
stocks

ASX retailer sees weaker sales growth as conditions soften

Momentum fades as consumer spending softens.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,255.2020.500.22%
CAC 408,501.917.45-0.09%
DAX 4026,091.3337.03-0.14%
Dow JONES (US)53,445.34101.940.19%
FTSE 10010,743.3515.310.14%
HKSE25,495.0723.920.09%
NASDAQ26,345.2455.530.21%
Nikkei 22565,326.422,134.30-3.16%
NZX 50 Index13,929.6763.490.46%
S&P 5007,716.4324.670.32%
S&P/ASX 2009,053.8025.200.28%
SSE Composite Index3,894.4295.88-2.40%

Market Movers